Roswitha Verwer explores whether the term FemTech helps or limits women’s healthcare, and why the future must move beyond visibility toward full integration in mainstream medicine.

Roswtha Verwer explores how delayed diagnosis in reproductive health drives emotional, financial, and clinical costs, and how earlier biological insight can reduce failed fertility cycles and unnecessary escalation.